24th October 2012
Exosect announces that it is future scoping the range of applications for its EntostatTM technology platform.
Winchester, UK – Exosect, today announced that it is now future scoping the range of applications for its EntostatTM technology platform. Entostat enables companies to deliver compounds and ingredients in a more effective or efficient way. The company is currently focused on applications that protect or enhance food production ‘pollen to plate’, but fully recognises the opportunity for further industry expansion into areas such as electronics, cosmetics, pharmaceutical, printing inks, etc.
Exosect has spent 12 years developing a robust patent portfolio and now has an expanding range of variants based on the original discovery. Importantly the company has become highly skilled in the manipulation of particle size, shape and density, which it has successfully applied in the development of novel solutions for the delivery of both chemical and biological agents.
The company operates by forming commercial collaborations through licensing with other organisations in the development of novel solutions that add value to the stakeholders. Companies interested in exploring opportunities for collaborations should contact Jane Terry, International Business Development Manager, firstname.lastname@example.org
Tel: +44 (0) 23 8060 3939
- Ends -